Drug Profile
Atractylodes japonica - SK Chemicals
Alternative Names: SKI-3246Latest Information Update: 30 Dec 2019
Price :
$50
*
At a glance
- Originator SK Chemicals
- Class Antiallergics; Herbal medicines; Irritable bowel syndrome therapies; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 30 Dec 2019 Discontinued - Phase-II for Irritable bowel syndrome in South Korea (PO)
- 06 May 2016 Phase-II development is ongoing in South Korea
- 31 Jan 2013 Phase-II clinical trials in Irritable bowel syndrome in South Korea (PO)